Plus: type 2 & flash glucose monitors; stroke and hyperglycemia
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

Jan. 14, 2020: DCMS #484

TOP STORIES - Diabetes News & Research

Teplizumab as Prophylaxis Therapy

Treatment of Hyperglycemia in Patients with Acute Ischemic Stroke

FreeStyle Libre FGM in Patients with Type 2 Diabetes


MOST POPULAR ARTICLES OF THE MONTH


Updated Consensus Report on Diabetic Nutrition Therapy

Oral Insulin (ORMD-0801) Close to Reality

Metformin Reduces Hospitalizations Associated with Heart Failure
Letter from the Editor
Jan. 14, 2020

I was speaking with our intern Usif Darwish, PharmD Candidate, Florida A&M University, about the causes of type 1 diabetes, and he focused on autoimmune problems destroying the beta cells.

He wondered out loud if using an autoimmune blocking drug would prevent diabetes in relatives of patients already diagnosed.

As you probably guessed, his thought became his assignment, and this week he brings us a feature on the value of using a monoclonal antibody drug.

We have moved our newsletters to a new server in order to provide you with a more robust experience. Please make sure to add news@mail.diabetesincontrol.com to your contacts/whitelist so you don’t miss a single issue.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief
Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

TOP STORIES - Diabetes News and Research

Teplizumab as Prophylaxis Therapy
The study findings shed light on the viability of a potential prophylactic treatment of type 1 diabetes in direct relatives of current patients
READ MORE
Treatment of Hyperglycemia in Patients with Acute Ischemic Stroke
SHINE study assesses outcomes of aggressive vs standard blood glucose treatments
READ MORE
FreeStyle Libre FGM in Patients with Type 2 Diabetes
Patients with type 2 diabetes routinely use self-monitoring of blood glucose, but what if there was a better option?
READ MORE
 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2019 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States

DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe